Parenteral Drug Association
 | This article relies largely or entirely on a single source. (November 2019) |
The Parenteral Drug Association (PDA) is an international non-profit industry trade group for pharmaceutical and biopharmaceutical manufacturers.
Founded in 1946 (77 years ago) as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry, it now has more than 11,000 members worldwide.[1]
Global organization
[edit]PDA has members in 74 countries and regions:
Africa
Botswana, Egypt, Ghana, South Africa, Tunisia, Zimbabwe
Asia
Bangladesh, China, India, Pakistan
Caribbean, Central, & South America
Argentina, Brazil, Colombia, Costa Rica, Dominican Republic, Paraguay,
Peru, Uruguay
Europe
Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia,
Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia,
Luxembourg, Malta, Netherlands, Norway, Poland, Portugal,
Romania, Russia, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland,
Ukraine, United Kingdom
Middle East
Cyprus, Iran, Palestine, Jordan, Saudi Arabia, Syria, Turkey, United Arab Emirates
North America
Canada, Mexico, Puerto Rico, United States
Pacific-Rim
Australia, Hong Kong, Indonesia, Japan,
Malaysia, New Zealand, Singapore, South Korea,
Taiwan, Thailand, Vietnam
References
[edit]- ^ "About PDA". Parenteral Drug Association. Retrieved 8 October 2015.